HealthRX.com · Printable symptom log
Wegovy constipation that has not settled: tier-by-tier record
Write down when constipation began against your dose steps, each tier you have tried and for how long, and your bowel pattern now, so the talk about prescription options or a dose change starts from facts. Label and trial figures and the red flags that end self-management are printed with it.
Timing and history
Date you started Wegovy
Date you reached your maintenance dose, and which dose
When constipation began, and your dose then
Abdominal surgery, inflammatory bowel disease or diverticular disease?
Other constipating medicinesopioids, iron, anticholinergics
Tiers you have tried
| Tier | Product or change, with amount | Start date | Weeks used | Result |
|---|---|---|---|---|
| Fiber and fluids | ||||
| Osmotic laxative | ||||
| Prescription option | ||||
| Dose change with prescriber |
Bowel record
| Date | Bowel movement? Stool form | Days since the last one | Straining or incomplete emptying | Bloating, pain or vomiting |
|---|---|---|---|---|
Figures to bring to the review
- Wegovy label: constipation was reported by 24% of adults on 2.4 mg against 11% on placebo in the weight trials.[1]
- STEP 1 to 3: one constipation episode on semaglutide 2.4 mg lasted a median of 47 days, against 35 days on placebo.[2]
- Wegovy label: if a dose is not tolerated during escalation, consider delaying the next increase for 4 weeks; if 2.4 mg is not tolerated, the dose can be reduced to 1.7 mg.[1]
Seek prompt evaluation
- Ileus, intestinal obstruction and severe constipation with fecal impaction appear in the Wegovy label's postmarketing reports.[1]
- Severe pain in the stomach area that will not go away: stop Wegovy and call your healthcare provider right away.[1]
For the review
- Is it time for an osmotic laxative, and for how long?
- Would a prescription secretagogue or prucalopride suit my situation?
- Should my dose be held, or stepped down for a while?
- Does my surgical or bowel history mean I should be examined or imaged sooner?
Sources for the facts on this sheet
- Novo Nordisk, via DailyMed. Wegovy (semaglutide) injection and tablets: prescribing information and Medication Guide. Effective 2026-06-18. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab 2022. PMID 34514682. https://pubmed.ncbi.nlm.nih.gov/34514682/
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.